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Abstract
Background: Hemophilia is an inherited genetic disease characterized by the inability to coagulate blood after injury. The ratio-
nale of  the current study was  to evaluate serum proteins S and C and correlate to kidney function test in hemophilic patients 
for early diagnosis of  abnormality in renal function.
Subjects and Methods: This study was conducted on 80 males subjects divided into four groups. Group I: Control: Healthy 
subjects. Group II: Renal dysfunction (serum Creatinine >2mg/dl): Group III: Hemophilic patients. Group IV: Hemophilic 
patients with renal disorder. Serum urea, creatinine, sodium, potassium, protein C and protein S level were determined. 
Resuts: Protein C and S levels showed a significant decrease in hemophilic/and with renal dysfunction (P < 0.001,p<0.001). 
The level of  plasma protein C and S levels were positively correlated with increased urinary albumin (P < 0.01). Urinary albumin 
was increased about 15 folds in hemophilic patients with renal dysfunction and nephrotic patients as compared with the control 
group.  The cut-off  value in 90% patients at the hemophilic patients with renal dysfunction 70%. Positive correlations were 
observed between urinary albumin (r=0.66), and creatinine (r=0.73). 
Conclusion:  These biomarkers showed good predictive values with regard to ROC-AUC (0.41 and 0.75 for Proteins C and S, 
respectively).
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Background
Hemophilia, is an inherited genetic disease. In this condi-
tion, the ability of  one’s body to make blood clots is im-
paired. Clotting of  blood is needed to stop bleeding from 
injuries. As a consequence, the bleeding lasts long after 
an injury and even the risk of  bleeding inside joints or 
the brain increases. People who are born with hemophilia 
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either have little or no clotting factors. Hemophilia A and 
hemophilia B are the two main types. Type A occurs due 
to the defect in the synthesis of    factor VIII , while type 
B is due to defect in factor IX synthesis. Both types are 
chromosome X linked and affect male live births.  The 
alterations in the intrinsic pathways of  blood coagulation 
are determined1-6.
Protein C, is blood coagulation factor IV, synthesized as 
inactive zymogen and activated by partial proteolysis.  It 
plays a vital role in regulation of  anticoagulation7. It also 
plays a role in cell death, maintaining the permeability 
of  blood vessel walls and inflammation. This zymogenic 
form is a vitamin K dependent glycoprotein. The acti-
vated protein C (APC) performs these functions mainly 
via proteolytic inactivation of  the proteins, like Factor Va 
and Factor VIIIa8. Protein is structurally similar to oth-
er vitamin K dependent glycoproteins that affect blood 
clotting, like, prothrombin, Factor VII, Factor IX and 
Factor X9. This protein C zymogen is activated in coagu-
lation- thrombin, and is greatly enhanced by the presence 
endothelial protein C receptors. It is encoded by PROC 
gene10, if  protein C is deficient or there is any resistance 
to APC, it may result in an increased risk of  forming dan-
gerous blood clots, a condition called arterial embolism.
Protein S is glycoprotein, synthesized in the endothelium. 
This protein is vitamin K dependent. Protein S plays a 
role crucial in the anti-coagulation pathway as a co-factor 
to protein C, in rendering Factors Va and VIIIa inactive5. 
In humans, protein S is encoded by the PROS1 gene6, 7. 
The mutations in the gene PROS1 lead to deficiency of  
protein S level , which increases the risk of  arterial embo-
lism8,9. As mentioned earlier, among the anti-coagulation 
components of  the human body, Protein C plays a major 
role. The proteins that are made inactive by APC, Factor 
Va and Factor VIIIa, (via proteolysis of  peptide bonds in 
proteins Factors V and VIII respectively), act as cofactors 
for formation of  thrombin  which is required in the pro-
cess of  blood clotting and they form the prothrombinase 
complex together10. Protein S acts a co-factor in the in-
activation of  protein factors Va and VIIIa. Prothrombin 
and Factor Xa bind to protein Factor Va, and enhances 
the rate of  thrombin production. Thus, by inactivating 
the protein factor Va, thrombin production is halted. 
Moreover, protein Factor VIII, acts as a cofactor for pro-
ducing activated Factor X, which activates prothrombin 
into thrombin11. Protein Factor VIIIa further greatly en-
hances the activation of  Factor X. Factor VIII is known 
as anti-hemophilic factor, because of  the fact that it plays 
a major role in blood clotting.  Hence, the deficiency of  
this Factor VIII causes hemophilia A12.
 
 
Fig: Blood coagulation and Protein C anticoagulation pathway. 
The current study aimed to evaluate serum proteins S and 
C and correlated them to kidney function tests in hemo-
philic patients for early diagnosis of  abnormality in renal 
function  to avoid its complications.
Subjects and methods
Informed consent was taken from all individuals included 
in this study. The study was done according to the ethical 
committee of  King Abdulaziz University. This study was 
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conducted on 80 male  subjects  admitted at the Hema-
tology Department ,King Abdulaziz University hospital . 
All individuals were subjected to full clinical examination 
(diabetes,hypertension, cardiovascular disorder. They 
were classified according to clinical examination to the 
following groups:
 
Group I: Control: Included 20 healthy subjects, no evi-
dence for any symptoms of  clinical disorder.
Group II: Renal diseases: Included 20 patients confirmed 
to have renal disorder by clinical examination and elevat-
ed serum creatinine and micro-albuminuria.  
Group III: Hemophilic patients:  Included 20 hemophilic 
patients : This group were confirmed to have hemophilic 
by clinical examination and hematological parameters.
Group IV: Hemophilic patients with renal disorder: In-
cluded 20 hemophilic patients with renal function disor-
der.  A five ml blood sample was collected from each sub-
jects. Serum was obtained by centrifugation at 4000 r.p.m 
for 10 minutes.  Serum was stored at –80 °C until used.
The exclusion criteria include patients with diabetes, re-
nal disease, cardiovascular disease, neoplastic, or hepatic 
damage and were matched for age and body mass index 
with no history of  liver disease.
Serum samples were subjected to the following examina-
tion. Serum urea, creatinine, sodium, potassium, protein 
C and protein S levels, urinary albumin were determined 
by available kits obtained from Bio diagnostic company.
Statistical analysis
Results were expressed as mean ± SD. Sensitivity was cal-
culated as: (patients with positive markers)/ (all patients); 
specificity was calculated as: (patients with negative mark-
ers)/(all patients). Results were compared using Student’s 
t test for continuous variables and chi-square analysis .A 
p value ≤0.05 was considered significant. One-way ANO-
VA was additionally used as a confirmatory test.
Results
Table (1) showed that serum urea and creatinine lev-
els were significantly elevated in microalbuminuria with 
nephrotic syndrome compared with control groups (p 
<0.001) for both. Serum urea and creatinine were statis-
tically significantly elevated in hemophilic patients with 
renal dysfunction compared with hemophilic and renal 
dysfunction groups (p <0.001) for both. ANOVA analy-
sis showed non-significant changes which were observed 
between nephrotic syndrome and nephrotic with hemo-
philic. Non-significant changes in the levels of  sodium 
and potassium in all groups compared with the controls. 
Plasma   protein C and S levels showed a significant de-
crease in hemophilic/and with renal dysfunction (P < 
0.001, p <0.001) .The level of  plasma protein C and S 
levels were positively correlated with increase in urinary 
albumin (P < 0.01). Urinary albumin was increased about 
15 folds in hemophilic patients with renal dysfunction 
and nephrotic and compared with control group. 
African Health Sciences Vol 18 Issue 3, September, 2018 683
Table (1). The levels of serum urea, creatinine sodium, potassium, in 
all studied groups (mean ±SD). 
 




























































































































n = number of cases p1value, hemophilic, renal dysfunction and hemophilic with renal dysfunction  
versus control.   p2 value , hemophilic with renal dysfunction versus renal dysfunction. 
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Table (2). The levels of serum protein C and S and urinary albumin in 
all studied groups (mean ±SD) 
 


































































































n = number of cases p1value, hemophilic, renal dysfunction and hemophilic with renal dysfunction versus 
control.   p2 value , hemophilic with renal dysfunction versus renal dysfunction. 
 
 
Table 3. Receiver operating curve (ROC)  analysis of investigated  urine  
parameters as a test for diagnosis of diabetic nephropathy 
  
Variable                                  protein C       protein S                          Creatinine                          
AUC                                           0.9                 0.73                                     0.92 
Sensitivity (%)                         89 %             92.3%                                  95.5%   
Specificity (%)                         90.4%            89.9%                                  97%          
AUC; area under curve 
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The cut-off  value in 90% patients at the hemophilic with 
renal dysfunction 70%. Positive correlations were ob-
served between urinary albumin (r=0.66), and creatinine 
(r=0.73) while were not correlated with other laboratory 
markers such as plasma urea and sodium and potassium.
Receiver operating curve (ROC) analysis  was performed 
to define the diagnostic profile of  urine level markers 
among subjects with diabetes. The serum level of  pro-
tein C showed an area under curve (AUC) of  0.92 with 
(sensitivity 91.0 % and  specificity, 88%). Also, the protein 
S supported the diagnostic profile, showing an AUC of  
0.75 with (sensitivity, 91.0%; specificity, 90.9%).
 
Discussion
Protein S aids APC in the proteolysis of  Factor Va, by 
making three cleavages (at Arg 306, Arg 506, Arg 679). 
The first two cleavages make Factor Va’s attraction to 
Factor Xa to diminish and after the cleavage at the first 
site, functioning of  Factor V is hampered. Furthermore, 
Protein S binds to Factor Xa, and inhibits it from dimin-
ishing the inactivation of  Factor Va, that was caused by 
APC13,14. Protein S also assists APC to inactivate Factor 
VIIIa via proteolysis (at sites Arg 336 and Arg 562), thus 
disabling it15,16.
Chronic renal dysfunction is considered a health problem 
worldwide and is a risk for increased morbidity and mor-
tality. Early sensitive assessment of  renal function is serv-
ing as a screening protocol for monitoring disease devel-
opment and prognosis. Identification of  biomarkers for 
evaluating kidney function contributes to the therapeutic 
protocol and avoids its complications17.
Nephropathy is the most common complication of  
many diseases include hemophilia and can lead to renal 
failure. Here, we tried to find a sensitive biomarker for 
diagnosis of  early phase of  nephropathy in hemophilic 
patients. Micro-albumunuria as a result of  impairment of  
the filtration of  the glomerular basement membrane is 
used as predictive of  renal impairment. Patients were cat-
egorized into 4 groups (normal, hemophilic, nephropathy 
and hemophilic with nephritic syndrome). Early diagno-
sis of  nephropathy in hemophilic patients is necessary to 
initiate appropriate treatment. Elevation of  serum urea, 
creatinine and urinary albumin are the most markers that 
physicians depend on in diagnosis. In the present study, 
serum creatinine and urea were positively correlated and 
good index for renal impairment.
Data obtained showed that, Protein C and S levels in plas-
ma were significantly increased in patients with nephrop-
athy and hemophilic with nephritic syndrome compared 
with control or hemophilic. It was expected that this in-
crement was probably due to the tubular phase before 
glomerular manifestation. This results in accordance of  
previous study, which stated that, there is a significant el-
evation in protein C and S in subjects with hemophilic 
and hemophilic with renal disorder compared with con-
trol subjects17-21.  This suggests that the proteins C and S 
levels of  plasma were related to tubular impairment and 
can be an earlier measurable marker of  renal involvement 
before onset of  albuminuria. This finding indicated that 
the proteins C and S levels could be an index reflecting re-
nal tubular epithelial cells. However, plasma endogenous 
creatinine depends on creatinine synthesis, metabolism 
to creatinine and tubular clearnce. Moreover several tu-
bular proteins are excreted even before the detection of  
micro-albuminuria and elevation of  plasma creatinine22,23. 
Therefore, other biomarkers for evaluation of  renal func-
tion have been found and one of  them was protein C. 
It was suggested that proteins S and C may be one of  
the additional tubular markers which represent the kidney 
state of  hemophilic patients.
It was found that, renal function was inversely associated 
with urine albumin excretion, which is a good predictor 
of  decline in kidney function than albuminuria24,25. This 
is in agreement with the present study that showed a pos-
itive correlation between nephrotic syndrome with levels 
of  proteins C and S. Since its excretion in urine is associ-
ated with nephritic syndrome while it is a good predictor 
which may detect the eventual need for renal function 
monitoring.
Proteins C and S were decreased in  95% at the  diabetic 
microalbuminuric stage and 87% at the nephrotic syn-
drome, which indicated that it might be a useful biomark-
er for detecting early injury in hemophilic  patients .
Conclusion 
These biomarkers showed good predictive values with re-
gard to ROC-AUC (0.41 and 0.75 for Proteins C and S 
respectively).
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